By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS








Company News
Soligenix (SNGX) Receives Positive Scientific Advice From The EMA For SGX942 In The Treatment Of Oral Mucositis In Head And Neck Cancer Patients 1/5/2017 8:52:28 AM
Soligenix (SNGX) Announces Extension of Development Agreement With Emergent BioSolutions (EBS) 1/3/2017 6:58:18 AM
Soligenix (SNGX) Advances Collaboration With IDT Biologika 12/20/2016 9:22:22 AM
Soligenix (SNGX) Announces Closing Of Public Offering 12/19/2016 9:48:43 AM
Soligenix (SNGX) Prices $5,277,000 Public Offering And Completes Listing On Nasdaq 12/13/2016 6:48:13 AM
Soligenix (SNGX) Announces SGX942 Receives Promising Innovative Medicine Designation From The UK Medicines And Healthcare Products Regulatory Agency 12/12/2016 7:56:13 AM
Soligenix (SNGX) Announces Positive Long-Term Follow-Up Results From Its Phase 2 Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients 12/8/2016 6:51:59 AM
Soligenix (SNGX) Announces Recent Accomplishments And Third Quarter 2016 Financial Results Highlighted By Revenues Of $3.0 Million 11/11/2016 1:31:45 PM
Soligenix (SNGX) Receives EMA Designation As Small And Medium Enterprise 10/25/2016 6:55:26 AM
Soligenix (SNGX) Announces Publication Of Its Phase 2 Clinical Trial Results Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients 10/18/2016 7:33:58 AM
12345678910...
//-->